What is Wolff-Parkinson-White (WPW) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wolff-Parkinson-White (WPW) Syndrome

Wolff-Parkinson-White syndrome is a congenital cardiac condition characterized by the presence of an accessory electrical pathway between the atria and ventricles that bypasses the normal AV nodal conduction system, resulting in ventricular pre-excitation and increased risk of tachyarrhythmias and sudden cardiac death. 1, 2

Definition and Electrocardiographic Features

WPW syndrome is defined by:

  • Specific ECG pattern (WPW pattern) showing:
    • Short PR interval (<120 ms)
    • Delta wave (slurring of the initial QRS upstroke)
    • Widened QRS complex (>120 ms)
  • Presence of symptomatic tachyarrhythmias 2

The prevalence of WPW pattern on ECG ranges from 0.1% to 0.3% in the general population 1, 2.

Pathophysiology

WPW syndrome results from:

  • Abnormal accessory pathway (AP) connecting atria and ventricles
  • Bypass of the normal AV nodal delay
  • Creation of a potential reentry circuit that can sustain tachyarrhythmias 2

Types of accessory pathways include:

  • Manifest pathways (conduct antegrade, visible on ECG)
  • Concealed pathways (conduct only retrograde, not visible on resting ECG)
  • Decremental pathways (slow conducting, like PJRT) 1, 2

Clinical Manifestations and Associated Arrhythmias

Common arrhythmias in WPW syndrome:

  1. Orthodromic AVRT (95% of cases):

    • Antegrade conduction through AV node
    • Retrograde conduction through accessory pathway
    • Presents as narrow QRS tachycardia 2
  2. Antidromic AVRT (less common):

    • Antegrade conduction through accessory pathway
    • Retrograde conduction through AV node
    • Presents as wide QRS tachycardia 2
  3. Atrial Fibrillation (AF):

    • Occurs in up to 50% of WPW patients
    • Can conduct rapidly through accessory pathway
    • Highest risk for sudden cardiac death 3, 2
  4. Permanent Junctional Reciprocating Tachycardia (PJRT):

    • Involves slowly conducting posteroseptal accessory pathway
    • Characterized by long RP interval 1, 2

Risk Stratification

High-risk features for sudden cardiac death:

  • Shortest pre-excited R-R interval <250 ms during atrial fibrillation
  • History of symptomatic tachycardia
  • Multiple accessory pathways
  • Posteroseptally located pathways 1, 2

The 10-year risk of sudden cardiac death ranges from 0.15% to 0.24% in patients with WPW 1. The risk appears highest in the first two decades of life 1.

Low-risk features:

  • Intermittent pre-excitation
  • Abrupt loss of pre-excitation during exercise
  • Loss of pre-excitation after drug administration (ajmaline, procainamide) 1, 2

Acute Management

For orthodromic AVRT:

  1. Vagal maneuvers (first-line) 1
  2. Adenosine (if vagal maneuvers fail) 1
  3. Synchronized cardioversion for hemodynamically unstable patients 1

For pre-excited atrial fibrillation:

  1. Immediate synchronized cardioversion for hemodynamically unstable patients 1
  2. Ibutilide or IV procainamide for hemodynamically stable patients 1

CAUTION: AV nodal blocking agents (calcium channel blockers, beta-blockers, digoxin) should be avoided in pre-excited AF as they can enhance conduction through the accessory pathway and potentially precipitate ventricular fibrillation 2.

Definitive Management

Catheter ablation is the first-line definitive treatment for symptomatic WPW syndrome, with success rates exceeding 95% and complication rates of 1-2% in experienced centers. 1, 2

Indications for catheter ablation:

  • Symptomatic tachyarrhythmias
  • Documented atrial fibrillation with rapid ventricular response
  • Survivors of ventricular fibrillation
  • High-risk occupations (pilots, athletes, heavy machinery operators) 1, 2

For asymptomatic patients with incidental WPW pattern:

  • Risk stratification should guide management
  • Catheter ablation may be considered in high-risk professions or athletes
  • Observation may be appropriate for truly low-risk patients 1, 2

Special Considerations

In athletes:

  • Comprehensive risk evaluation before competitive sports participation
  • Catheter ablation recommended for symptomatic athletes or those with high-risk features 1

Associated conditions:

  • Ebstein's anomaly
  • Hypertrophic cardiomyopathy
  • Other structural heart diseases 2

Prognosis

With appropriate management:

  • Excellent prognosis following successful ablation
  • Normal life expectancy
  • Low recurrence rate (5-10%) after ablation 2

Most asymptomatic patients with WPW pattern have a good prognosis, but sudden cardiac death can be the first manifestation of the disease in some cases 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Extranodal Pathways

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.